Aurinia Pharmaceuticals Inc. SEC filings AUPH

Aurinia Pharmaceuticals Inc. has 615 filings in SEC EDGAR's recent list, going back to Feb 28, 2014. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.

Aurinia Pharmaceuticals Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 30, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 30, 2026 Oct 30, 2026
4 Insider transaction Sep 11, 2026 Sep 10, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 26, 2026 —
4 Insider transaction Aug 25, 2026 Aug 21, 2026
144 Notice of proposed sale Aug 21, 2026 —
8-K Current report
Other events
Aug 19, 2026 Aug 19, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
144 Notice of proposed sale Jun 5, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 4, 2026 —
8-K Current report
Shareholder vote results
Jun 4, 2026 Jun 3, 2026
144 Notice of proposed sale Jun 4, 2026 —
4 Insider transaction Jun 2, 2026 May 29, 2026
144 Notice of proposed sale Jun 2, 2026 —
4 Insider transaction May 20, 2026 May 18, 2026
4 Insider transaction May 20, 2026 May 18, 2026
4 Insider transaction May 20, 2026 May 18, 2026
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 11, 2026 —
8-K Current report
Acquisition or sale of assets
May 11, 2026 May 8, 2026
SC TO-T/A Filing May 11, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
DEF 14A Proxy statement Apr 21, 2026 Jun 3, 2026
SC TO-T Filing Apr 13, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 3, 2026 Mar 30, 2026
3 Initial insider ownership Apr 2, 2026 Mar 23, 2026
3 Initial insider ownership Apr 2, 2026 Mar 23, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 25, 2026 —
8-K Current report
Officer or director change
Mar 23, 2026 Mar 20, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 3, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 23, 2026 Feb 20, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Nov 24, 2025 Nov 21, 2025
4 Insider transaction Nov 24, 2025 Nov 21, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 13, 2025 —
4 Insider transaction Aug 5, 2025 Aug 1, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Results of operations, Other events
Jul 31, 2025 Jul 31, 2025
8-K Current report
Other events
Jun 30, 2025 Jun 30, 2025
4 Insider transaction May 16, 2025 May 16, 2025
4 Insider transaction May 16, 2025 May 16, 2025
4 Insider transaction May 16, 2025 May 16, 2025
4 Insider transaction May 16, 2025 May 16, 2025
3 Initial insider ownership May 16, 2025 May 15, 2025
3 Initial insider ownership May 16, 2025 May 15, 2025
S-8 Employee stock plan registration May 16, 2025 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
May 15, 2025 May 15, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
DEFA14A Additional proxy material Apr 30, 2025 —
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 17, 2025 May 15, 2025
4 Insider transaction Mar 7, 2025 Mar 7, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 4, 2025 —
4 Insider transaction Mar 4, 2025 Feb 28, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Dec 9, 2024 Dec 5, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 12, 2024 Nov 8, 2024
4 Insider transaction Nov 12, 2024 Nov 8, 2024
3 Initial insider ownership Nov 12, 2024 Nov 7, 2024
3 Initial insider ownership Nov 12, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations, Exit or restructuring costs, Officer or director change
Nov 7, 2024 Nov 7, 2024
3 Initial insider ownership Sep 23, 2024 Sep 12, 2024
4 Insider transaction Sep 20, 2024 Sep 9, 2024
SC 13D Ownership over 5% (active) Sep 12, 2024 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Sep 12, 2024 Sep 9, 2024
4 Insider transaction Aug 8, 2024 Aug 6, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
8-K Current report
Shareholder vote results
Jun 14, 2024 Jun 14, 2024
DEFA14A Additional proxy material Jun 4, 2024 —
DEFA14A Additional proxy material Jun 4, 2024 —
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 22, 2024 May 21, 2024
ARS Annual report to shareholders May 3, 2024 Dec 31, 2023
DEFA14A Additional proxy material May 3, 2024 —
DEF 14A Proxy statement May 3, 2024 Jun 14, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report
New debt
May 2, 2024 May 2, 2024
10-K/A Amended annual report Apr 29, 2024 Dec 31, 2023
SC 13D/A Amended ownership over 5% (active) Mar 20, 2024 —
4 Insider transaction Mar 7, 2024 Mar 6, 2024
4 Insider transaction Mar 7, 2024 Mar 6, 2024
4 Insider transaction Mar 7, 2024 Mar 6, 2024
4 Insider transaction Mar 7, 2024 Mar 6, 2024
4 Insider transaction Mar 7, 2024 Mar 6, 2024
4 Insider transaction Feb 29, 2024 Feb 27, 2024
8-K Current report
Officer or director change
Feb 29, 2024 Feb 27, 2024
4 Insider transaction Feb 22, 2024 Feb 20, 2024
4 Insider transaction Feb 22, 2024 Feb 20, 2024
4 Insider transaction Feb 22, 2024 Feb 20, 2024
4 Insider transaction Feb 22, 2024 Feb 20, 2024
4 Insider transaction Feb 22, 2024 Feb 20, 2024
4 Insider transaction Feb 22, 2024 Feb 20, 2024
4/A Form 4/a Feb 22, 2024 Mar 2, 2023
4/A Form 4/a Feb 22, 2024 Mar 2, 2023
4/A Form 4/a Feb 22, 2024 Mar 2, 2023
10-K Annual report Feb 15, 2024 Dec 31, 2023
8-K Current report
Results of operations, Exit or restructuring costs, Other events
Feb 15, 2024 Feb 15, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
8-K Current report
Results of operations
Jan 5, 2024 Jan 5, 2024
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
4 Insider transaction Sep 22, 2023 Sep 21, 2023
3 Initial insider ownership Sep 22, 2023 Sep 21, 2023
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Sep 21, 2023 Sep 21, 2023
4 Insider transaction Aug 21, 2023 Aug 18, 2023
3 Initial insider ownership Aug 21, 2023 Aug 18, 2023
4 Insider transaction Aug 21, 2023 Aug 18, 2023
3 Initial insider ownership Aug 21, 2023 Aug 18, 2023
8-K Current report
Officer or director change
Aug 21, 2023 Aug 18, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
PX14A6G Filing Jul 6, 2023 —
8-K Current report
Officer or director change, Other events
Jul 3, 2023 Jun 29, 2023
PX14A6G Filing Jun 1, 2023 —
S-8 Employee stock plan registration May 26, 2023 —
4 Insider transaction May 23, 2023 May 18, 2023
4 Insider transaction May 23, 2023 May 18, 2023
4 Insider transaction May 23, 2023 May 18, 2023
4 Insider transaction May 23, 2023 May 18, 2023
4 Insider transaction May 23, 2023 May 18, 2023
4 Insider transaction May 23, 2023 May 18, 2023
4 Insider transaction May 23, 2023 May 18, 2023
8-K Current report
Shareholder vote results
May 17, 2023 May 17, 2023
PX14A6G Filing May 17, 2023 —
PX14A6G Filing May 11, 2023 —
SC 13D/A Amended ownership over 5% (active) May 10, 2023 —
DEFA14A Additional proxy material May 8, 2023 —
PX14A6G Filing May 5, 2023 —
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
PX14A6G Filing May 3, 2023 —
DEFA14A Additional proxy material May 2, 2023 —
DEFA14A Additional proxy material Apr 28, 2023 —
PX14A6G Filing Apr 26, 2023 —
DEF 14A Proxy statement Apr 18, 2023 —
8-K Current report
Regulation FD disclosure
Apr 5, 2023 Apr 5, 2023
8-K Current report
Other events
Mar 13, 2023 Mar 13, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G Ownership over 5% (passive) Feb 7, 2023 —
8-K Current report
Other events
Jan 27, 2023 Jan 24, 2023
SC 13D/A Amended ownership over 5% (active) Jan 20, 2023 —
8-K Current report
Results of operations
Jan 9, 2023 Jan 6, 2023
SC 13D/A Amended ownership over 5% (active) Jan 6, 2023 —
8-K Current report
Other events
Jan 3, 2023 Jan 3, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AUPH (Nasdaq)
Fiscal year ends
December 31
Headquarters
Edmonton, Alberta, Canada
SEC filer status
Large accelerated filer
SEC CIK
1600620

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.